Amer Aldouri MBChB MD MRCS FRCS

• (Hepatobiliary)
• Specialist registrar in surgery
• St James? University Hospital, Leeds, UK

However medications in canada cheap retrovir 100 mg, it is more likely that digital subtraction angiography underestimated asymmetric stenoses because of the limited number of carotid artery projections available symptoms gallstones purchase cheap retrovir on line. It remains highly sensitive and specific for the diagnosis of high-grade carotid stenoses medications 6 rights 300 mg retrovir purchase mastercard. In a 2006 meta-analysis medications containing sulfa purchase retrovir 300 mg line, the sensitivity and specificity for diagnosis of a 70% to 99% carotid stenosis were 94% and 93% medications 6 rights retrovir 300mg buy without prescription, respectively, compared with invasive angiography. Ultrasonography can overestimate nearocclusions, which can preclude beneficial surgical therapy if the lesion is misclassified as a total occlusion. The diffuse irregularity and fusiform aneurysm of the abdominal aorta reflect extensive atherosclerosis. It performs well in determining the location and degree of atherosclerotic stenosis and has rendered invasive diagnostic angiography almost unnecessary. Care should be taken, however, as metal clip or metallic stent artifacts can appear similar to stenosis or mimic arterial occlusion. Unfortunately, more caution must be taken given the recently discovered risk of nephrogenic systemic fibrosis. It has a more limited role in the evaluation of patients with renal stents because of artifact that limits intra-stent analysis of stenosis. In addition, vascular access in these patients who are often severely ill is limited. Specificity is limited by occasional inability to analyze the inferior mesenteric artery. Nuclear Medicine/Positron Emission Tomography Radionuclide techniques to evaluate noncoronary atherosclerotic disease currently have very limited clinical value. Positron emission tomography and single photon emission computed tomography can image both perfusion and metabolic abnormalities and provide a functional assessment of their disease in quantifiable fashion. They also have more background research to validate their findings and are often less expensive and faster. There are currently no clinical applications of metabolic imaging in noncoronary atherosclerosis, and promising agents, such as radiolabeled platelets and lipoproteins, have ongoing technical limitations. Ongoing research and technical advancement may identify relevant metabolic tracers and increase the role of these imaging modalities in the future. It has been considered the gold standard for defining vascular anatomy and pathology. Digital subtraction angiography has intrinsic high resolution, and individual vessels can be selectively evaluated. Moreover, hemodynamic information can be captured to evaluate physiology, whereas it can be estimated only indirectly with noninvasive techniques. Bolus chasing, rapid acquisition of images, three-dimensional reconstruction, and smaller catheters have further improved the utility of digital subtraction angiography, which decreases the dose of contrast material, improves visualization of the vascular tree, and speeds acquisition time compared with conventional angiography. For these reasons, other noninvasive techniques have been improved and have replaced angiography as the first-line diagnostic test for many indications. Angiography is now typically reserved for resolution of conflicting or inadequate noninvasive results and for therapeutic intervention. Conventional cerebral angiography has been the gold standard to evaluate for carotid stenoses. It evaluates the entire carotid system and can provide important ancillary information, such as collateral flow. Moreover, because of the limited number of projections attainable, digital subtraction angiography can underestimate the degree of stenosis when eccentric plaques are present. For these reasons, angiography is considered only for patients with conflicting results or scheduled for therapeutic intervention. Smaller catheters, improved access site choice (such as radial access), and closure device use have improved the safety of this procedure. It is important that suspected vessels be selectively imaged; this improves the overall accuracy and reduces the burden of contrast material. A complete study should include assessment of the major bifurcations in profile without vessel overlap (iliac, femoral, and tibial), and indeterminate lesions should have translesional pressure gradients measured. Conventional angiography is still frequently used in the assessment of renal artery stenosis because it can be performed as an adjunct assessment at the time of coronary or peripheral angiography. This is performed either through direct renal artery cannulation or "flush" aortography. In other settings, noninvasive testing is typically the first-line investigation, especially in patients at higher risk of complications, such as those with diabetes or renal disease. Contrast-induced renal failure occurs less than 3% of the time in patients without significant risk factors, 5% to 10% of the time in patients with diabetes or renal dysfunction, and in 10% to 50% of those with both comorbid conditions. Preprocedural oral administration of Nacetylcysteine may lower this risk to a small degree. In many instances, proceeding directly to exploratory laparotomy is the appropriate course. Bilateral atherosclerotic changes and occlusion of the right tibioperoneal trunk (arrow) are apparent. This approach is best for patients who present long after symptom onset, with an unclear diagnosis, or with a high likelihood of nonocclusive disease. Angiography should not be used in those with concurrent hypotension or in the setting of vasopressors because these can falsely mimic nonocclusive disease. An important caveat is that the majority of chronic mesenteric disease occurs at the origin of the major mesenteric arteries, such as the superior and inferior mesenteric arteries. Angiography may miss these lesions if the catheter is selectively engaged into the partially obstructed vessel. In complete superior mesenteric artery origin occlusion, the entire vessel may not be seen, the "naked aorta" sign. A prominent meandering artery can represent an enlarged marginal artery of Drummond rather than chronic atherosclerotic disease. Differential Diagnosis Clinical Presentation the differential diagnosis for noncoronary atherosclerosis is broad and specific to the arterial bed affected (Table 88-4). Consideration of any possible alternative diagnoses is essential before further invasive testing or therapy is undertaken. The key to differentiating cerebrovascular arterial disease from other intracranial processes is to determine the presence of positive symptoms (such as head jerking) and negative symptoms (such as motor or sensory deficits), their time at onset and duration, chronicity of spells occurring, and whether associated symptoms are present. This is often difficult, and further noninvasive imaging to define atherosclerotic disease combined with other tests, such as electroencephalography, is essential for a definitive diagnosis. For instance, seizures and migraine headaches often have associated positive symptoms that are rare with transient ischemic attacks or strokes from carotid or vertebrobasilar atherosclerotic disease. The important differentiators are the location of the discomfort, the onset relative to exercise, and how the discomfort is ameliorated. Nerve root compression typically is manifested with sharp pain radiating down the leg. Spinal stenosis can occur just with standing and is relieved with leaning forward, hip arthritic pain can be present at rest, and venous claudication is usually associated with venous congestion and edema. Claudication rarely involves the foot, so processes isolated to this area usually represent another disease process. Other forms of secondary hypertension can lead to the same refractory hypertensive state as with renal artery stenosis. Persistent high blood pressure eventually causes renal dysfunction, as do other forms of renal parenchymal disease. Fibromuscular dysplasia causes similar narrowing (although with a characteristic "beads on a string" appearance). However, patients with this disorder are typically younger with fewer cardiovascular risk factors. Noninvasive imaging is essential to help narrow the differential and should be considered in those with a high risk of noncoronary atherosclerotic disease, as in those with multiple cardiovascular risk factors, especially advanced age, male gender, and ongoing tobacco use. Notable exceptions include fibromuscular dysplasia, although this typically affects the renal arteries throughout their course and has a unique appearance, and stenoses seen during assessment of the mesenteric arterial vasculature in the setting of pressor or peripheral vasoconstrictor use. Blood pressure­lowering agents have been shown to dramatically reduce the risk of stroke in both primary and secondary prevention settings. A meta-analysis of randomized controlled trials showed that antihypertensives, including diuretics and blockers, reduced stroke risk by approximately 40%. Lipid-lowering therapy is also essential to slow the rate of progression of atherosclerosis and potentially to stabilize plaques. Simvastatin lowered stroke risk by 23% and 25% in the Scandinavian Simvastatin Survival Study (4S) and Heart Protection Study (a study of high-risk patients with atherosclerosis or diabetes), respectively. The remaining statins are thought to have similar benefits through a class effect. A meta-analysis of 287 trials with 135,000 highrisk patients showed a 22% reduction in stroke with an antiplatelet regimen. Aspirin plus extended-release dipyridamole is just as effective as aspirin alone for reducing death and nonfatal stroke, but a clear benefit over aspirin is debatable after studies with conflicting findings. There is no benefit to warfarin and increased bleeding risk in this clinical situation. Certain classes have been shown to have beneficial effects in addition to their blood pressure­lowering effect. Lipid-lowering therapy is another essential component to retard the progression of atherosclerosis. Antiplatelet therapy is the third essential drug class that lowers cardiac and vascular events; a meta-analysis of 9716 patients in 42 trials showed a 23% odds reduction. Oral anticoagulants have minimal increased benefit and an increased bleeding risk and are contraindicated without an additional appropriate indication. Intensive control of other significant comorbid conditions, such as renal disease and diabetes, can markedly reduce events. Physician counseling is effective, leading to a 50-fold increase in 1-year cessation rates (increase from 0. The addition of nicotine replacement therapy increases the 1-year success rate to 16% and of bupropion to 30%. A meta-analysis of supervised exercise rehabilitation showed a more than 180% increase in walking time with just 30 minutes three times weekly. Exercise outside of structured programs does not have well-established benefit but is certainly expected to improve symptoms and function. Cilostazol is a phosphodiesterase type 3 inhibitor that improves treadmill time and quality of life. A meta-analysis of six trials showed an improved pain-free walking distance of 30% to 60%. Pentoxifylline (a methylxanthine derivative), L-arginine, propionyl-L-carnitine, and gingko biloba are less effective and not used as frequently. There is no clear benefit to the parenteral administration of pentoxifylline or prostaglandins. Aortic Atherosclerotic Disease Aneurysms are the primary manifestation of aortic atherosclerotic disease, most commonly in the descending aorta. Close surveillance and surgical intervention when the aneurysms reach the appropriate size are the primary treatment options. However, medical therapy is essential to slow the progression and to reduce the risk of rupture. Despite its importance, no specific therapy has been shown to reduce the rate of aneurysm growth. The greatest risk factors for rupture include tobacco use and uncontrolled hypertension. Ongoing tobacco use increases the aneurysm growth rate by 20% to 25% and significantly increases the risk of rupture. Although there is debate about whether statins retard aneurysm progression, these guidelines suggest that all such patients should be receiving a statin regardless. Blockers are also recommended under these guidelines; they also may slow aneurysm progression, although a randomized controlled trial did not show significant benefit. Renal Atherosclerotic Disease the medical treatment of renal atherosclerotic disease involves both control of the disease process itself and treatment of the resultant complications. Aggressive atherosclerotic risk factor control is necessary to attempt to slow the progression of renal atherosclerosis as for other arterial beds. Resistant, severe hypertension and progressive renal function decline are the two primary complications of renal atherosclerotic disease and stem from renal artery stenosis. Angiotensin-converting enzyme inhibitors, angiotension receptor blockers, calcium channel blockers, and blockers have all been shown to have some effect on renal artery stenosis­associated hypertension. Both angiotensin-converting enzyme inhibitors and angiotension receptor blockers have been shown to slow the decline in renal function. Medical therapy is often supportive, involving gastric decompression, hemodynamic support, aggressive intravenous antibiotics, and correction of metabolic acidosis. Thrombolytic therapy is rarely given and can be used only within 8 hours of abdominal pain onset with no clinical evidence of bowel necrosis or other lytic contraindications. In rare circumstances, intravenous heparin and continuous papaverine infusion (a potent vasodilator) can be used with close monitoring. In this situation, the risks of bleeding versus the antiplatelet benefits of aspirin should be carefully considered. Long-term aspirin use can reduce the risk of recurrent ischemia in the setting of acute or chronic ischemia. Unlike with coronary obstruction, revascularization is indicated only in patients with symptoms that induce significant lifestyle or vocational disability and have a reasonable likelihood of improvement with restoration of blood flow. Moreover, intermediate lesions should be evaluated with translesional pressure gradients with and without vasodilation. There are limited randomized trial data comparing revascularization to medical therapy.

The most common sites are the right atrium symptoms narcolepsy buy retrovir 100mg overnight delivery, left ventricle medications of the same type are known as generic retrovir 100 mg buy, and interatrial septum medications like xanax proven retrovir 300 mg. Half of patients with rhabdomyoma have tuberous sclerosis symptoms definition retrovir 100mg order on line, and virtually all patients with tuberous sclerosis have cardiac rhabdomyomas symptoms 14 days after iui buy cheap retrovir 100 mg. Manifestations of Disease Clinical Presentation Most cardiac lipomas are asymptomatic and are discovered during imaging or autopsy. C, Gross photograph of the left ventricular lipoma with fragments of cardiac muscle (asterisk); at surgery, the 2. Imaging Techniques and Findings Radiography Chest radiographs may be normal or show cardiomegaly. A true lipoma is more often round or oval instead of bilobed, discovered incidentally in younger patients or in patients with little mediastinal fat. Liposarcoma is also in the differential diagnosis of a fat-containing cardiac mass, although it usually contains significant soft tissue components. Ultrasonography Lipomas are nonspecific homogeneous, immobile echogenic masses on echocardiography. Thin strands of soft tissue attenuation septa may be present without any nodularity. Treatment Options Surgical resection is performed only for symptomatic cardiac lipomas. They show homogeneous fat signal intensity on all sequences, including decreased signal intensity on fatsuppressed sequences, and no enhancement with gadolinium. It is homogeneous and similar in signal intensity to subcutaneous or mediastinal fat on all sequences, with signal dropout on fat saturation sequences. A large amount of concomitant epicardial or mediastinal fat, or both, is often present. Cardiac lipomas typically do not have a bilobed appearance and can be found in any location within the heart. Cardiac liposarcoma is extremely rare, and nonlipomatous soft tissue components may be expected on imaging. Without fat saturation, the bilobed mass (arrow) has high signal intensity that matches the subcutaneous fat. With fat saturation, the mass (arrowhead) shows decreased signal intensity, which confirms its fatty composition. B, Horizontal long-axis cine image shows characteristic low signal intensity margin (arrowheads) outlining the lipomatous hypertrophy. Imaging appearance is diagnostic, with an hourglassshaped mass of fat attenuation or fat signal intensity in the interatrial septum. Paraganglioma Definition A cardiac paraganglioma is an extra-adrenal catecholamineproducing tumor derived from chromograffin neuroectodermal cells. Pathology Cardiac paragangliomas are usually masses 3 to 8 cm in diameter with encapsulated or infiltrative margins and central necrosis. Only 1% to 2% of pheochromocytomas or paragangliomas are found within the thorax, most of which are located in the posterior mediastinum. Cardiac paragangliomas typically manifest in adulthood, with an age range of 18 to 85 years (mean 40 years). Cardiac paraganglioma has been described in a patient with the Carney triad, which consists of gastrointestinal stromal tumor, pulmonary chondroma, and extraadrenal pheochromocytoma. At surgery, a 5 × 3 × 4 cm paraganglioma was identified straddling the foramen ovale. Depending on location and size, mass effect may cause obstruction or compression of adjacent mediastinal structures. On T2-weighted sequences, they are generally markedly hyperintense and may appear "light-bulb bright". These studies show focal abnormal uptake in almost all cases of cardiac paraganglioma and may show metastatic or multifocal disease. Clinical and laboratory abnormalities occurring with paragangliomas secondary to catecholamine excess are the most diagnostic findings. A and B, Intraoperative view of opened right atrium (A) and specimen photograph (B) reveal a glistening white, granular-appearing lesion containing pink tissue. Imaging findings cannot differentiate paraganglioma from primary cardiac sarcomas. Manifestations of Disease Clinical Presentation the clinical presentation of calcified amorphous tumor includes heart failure, syncope, and evidence of embolization. If the lesion is not resectable, heart transplantation and medical management with and blockade are options in symptomatic patients. Imaging Techniques and Findings Radiography Chest radiograph may show dense calcification within the cardiac silhouette. Ultrasonography Most lesions evaluated with echocardiography were pedunculated, intracavitary diffusely calcified masses. Computed Tomography There is little literature regarding cross-sectional imaging of calcified amorphous tumor of the heart. In the largest series of 11 cases, the age range at presentation was 16 to 75 years (mean 52 years). Microscopic analysis shows nodular deposits of calcium within a background of amorphous fibrinous material. A, Posteroanterior and lateral chest radiographs (narrow window) coned to the cardiac silhouette show a calcified masslike opacity (arrows) located in the right atrium. Treatment Options Treatment is surgical excision or heart transplantation if the infiltration is extensive. Only one quarter of primary cardiac tumors are malignant, and almost all are sarcomas. Gross section through the ventricles from a patient with metastatic melanoma reveals multiple intramural nodules (arrows), many showing hemorrhagic features, compatible with hematogenous metastases to the left ventricular myocardium. Imaging features that suggest malignancy are location on the right side of the heart; single or multiple, poorly marginated intramural or broad-based intracavitary masses; internal heterogeneity (suggesting necrosis); contiguous valvular involvement; invasion of regional veins or coronary arteries; and pericardial thickening, nodularity, or significant effusion. Multifocal intracardiac lesions are further evidence of malignancy, particularly in metastatic disease to the heart, rhabdomyosarcoma, and cardiac lymphoma. Lung metastases may reflect the presence of either an extracardiac primary tumor or a right-sided cardiac malignancy with tumor embolization. The pathways of spread include direct extension from a mediastinal or thoracic tumor, hematogenous spread, lymphatic spread, and intracavitary extension via the inferior vena cava or pulmonary veins. Lung carcinoma, breast carcinoma, mesothelioma, and other thoracic malignancies may directly invade the heart and pericardium by contiguous growth. Epithelial malignancies, such as lung or breast carcinoma, tend to metastasize to the heart via lymphatic channels; regional lymphadenopathy and pericardial involvement often accompany superficial myocardial infiltration in these cases. One autopsy series revealed cardiac involvement in 16% of disseminated Hodgkin and 18% of disseminated non-Hodgkin lymphoma patients. Endocardial or intracavitary metastases are unusual (5%), and the valves are almost always spared. On histologic examination, metastatic foci in the heart tend to show features that identify the primary extracardiac malignancy. Sarcomatous deposits from an extracardiac tumor may be difficult to discern, however, from a primary cardiac sarcoma with intracardiac spread of disease. In some instances, immunohistochemical markers may help to make the distinction between an extracardiac sarcoma and a primary cardiac sarcoma. Lymphomas and leukemias secondarily involve the heart via any of the above-described pathways, typically affecting pericardium, epicardium, and myocardium diffusely. The incidence of cardiac metastases, largely based on autopsy studies, is 2% to 18% (vs. In order of decreasing incidence, the most common malignancies to produce secondary cardiac involvement are lung carcinomas, lymphomas, breast carcinomas, leukemia, gastric carcinomas, melanoma, hepatocellular carcinoma, and colon carcinoma. A, Portable chest radiograph shows congestive heart failure with enlarged cardiomediastinal silhouette, diffuse ground-glass opacities, and prominent vasculature. D, Gross autopsy specimen photograph (coned to the left ventricle) reveals a bulky, infiltrative mass (asterisk) located within the wall of the left ventricle and interventricular septum, which was histologically confirmed as melanoma. There are additional widespread tumor nodules studding the pericardium (arrows) and endocardium (arrowheads). It may show global enlargement of the cardiac silhouette, however, if a large pericardial effusion is present. Pulmonary or mediastinal neoplasm, lymphadenopathy, or underlying metastatic disease in the lungs may be evident radiographically in some cases. Ultrasonography Transthoracic echocardiography in cardiac metastatic disease may show pericardial effusion or intracavitary, nonmobile and nonpedunculated masses, or both. Note also bowing of the interventricular septum and encasement of the ventricles, which support the diagnosis of cardiac tamponade. Intramural metastatic tumor deposits in the heart may be evident as myocardial-based nodules or masses. Most cardiac neoplasms are of low signal intensity on T1-weighted images and are brighter on T2-weighted images; they also tend to enhance after intravenous contrast medium administration. Differential Diagnosis Significant pericardial effusion in a patient with underlying malignancy may represent not only advanced neoplastic disease, but also concomitant infectious, drug-induced, radiation-induced, or idiopathic pericarditis. Histologic features include anastomosing vascular channels lined by malignant endothelial cells that may occasionally form atypical papillary tufts. Vacuoles containing red blood cells may be seen, and most lesions contain areas of necrosis. Malignancies most likely to involve the heart secondarily are lung and breast carcinomas, lymphomas, melanoma, and leukemias. Malignant pericardial effusion is often the first clinical expression of cardiac metastatic disease. Right atrial masses may reflect contiguous endovascular invasion by hepatic, renal, adrenal, or uterine malignancy. Manifestations of Disease Clinical Presentation Clinical presentation is often the consequence of a malignant, often hemorrhagic pericardial effusion producing pericardial tamponade, pericardial restriction, or right ventricular outflow obstruction. Right-sided cardiac tumors such as angiosarcoma may also produce pulmonary emboli. Angiosarcoma Definition Cardiac sarcomas arise from pleuropotential mesenchymal cells within the cardiac muscle. Angiosarcomas often infiltrate the pericardium, leading to malignant pericardial effusion. Prevalence Primary cardiac sarcomas as a group are rare (<25% of primary cardiac tumors). Ultrasonography Echocardiography may reveal a broad-based, chiefly intramural right atrial mass located near the inferior vena cava. Pericardial effusion or contiguous tumor extension into the pericardium, endocardium, and left atrial chamber may be identified. In many cases, associated pericardial thickening, nodularity, and effusion are present. These tumors tend to show strong, heterogeneous enhancement after contrast administration; this is termed a "sunray" appearance if pericardial tumor infiltration also enhances. B, There is neoplastic involvement of the pericardium, which is studded by multiple, prominently enhancing nodules (arrowheads) and contains pericardial effusion. Note diffuse enhancement of the pericardium surrounding a moderate pericardial effusion. C, Gross specimen photograph shows the mass (arrows) in identical orientation to B. The presence of a hemorrhagic pericardial effusion is particularly supportive evidence of angiosarcoma. Surgical intervention ranges from open biopsy to palliative debulking to wide surgical resection. Cardiac angiosarcoma is the only differentiated cardiac sarcoma that chiefly arises in the right atrium (90%). Other cardiac sarcomas tend to arise in the left atrium, or do not have a site predilection. Leiomyosarcoma Definition Leiomyosarcomas account for 8% to 10% of cardiac sarcomas and are chiefly located in the posterior wall of the left atrium. Pathology Histologic features of cardiac leiomyosarcoma include intracytoplasmic glycogen, perinuclear vacuoles, bluntend nuclei, fascicular growth at right angles, and cytoplasmic fuchsinophilia. Cardiac transplantation may be considered in advanced disease except when distal metastases are present. Imaging Techniques and Findings Radiography Although no specific reports are available concerning radiographic manifestations of leiomyosarcoma, the most common radiographic abnormality in cardiac sarcomas overall is cardiomegaly. Osteosarcoma Definition Cardiac sarcomas with osteosarcomatous differentiation arise almost exclusively (>95%) in the left atrium. Pathology Grossly, cardiac osteosarcomas are typically large tumors (4 to 10 cm) almost uniformly located within the posterior left atrial wall. Notably, these tumors are often pleomorphic and may contain areas of fibrosarcoma, chondrosarcoma, or giant cell tumor. Helpful differentiating features of osteosarcoma from myxoma include a broad base of attachment and signs of aggressive behavior including involvement of regional veins, pericardium, and mitral valve. C, Surgical specimen of opened left atrium shows a polypoid mass occupying the chamber with components of necrosis, hemorrhage, and cystic change. Manifestations of Disease Clinical Presentation Clinical presentation includes symptoms of dyspnea, congestive heart failure, mitral valve obstruction, pulmonary hypertension, and syncope. Manifestations of Disease Clinical Presentation Clinical presentation varies because the tumor may arise in any part of the heart, extend into the nearest chamber, and ultimately cause valvular obstruction. Histologic appearance of the tumor is essentially indistinguishable from cardiac metastasis of skeletal osteosarcoma, but metastatic osteosarcoma is usually deposited in the right atrium, whereas primary cardiac osteosarcoma arises in the left atrium.

Compared with vasodilator stress myocardial perfusion imaging symptoms 0f brain tumor retrovir 100mg order without a prescription, dobutamine has a slightly lower sensitivity with similar specificity for the diagnosis of coronary artery disease medicine the 1975 100 mg retrovir order otc. This issue is less clear with vasodilator testing medicine dosage chart cheap retrovir 100 mg, although limited studies have shown a significant decrease in individual vessel sensitivity with no change in specificity in patients on anti-ischemic medications at the time of testing medicine bow buy retrovir 100 mg with visa. For dobutamine testing medications narcolepsy buy retrovir without a prescription, blockers may blunt the capacity of the agent to achieve adequate stress heart rates for imaging, although this is usually overcome with atropine and isometric supine exercise. Generally, this blunting caused by blockers translates into no significant loss of sensitivity or specificity in patients on these medications, although most protocols advise patients to hold blockers before dobutamine stress imaging. Walking Adenosine Protocols For patients able to walk, it is advantageous to combine low-level exercise with adenosine myocardial perfusion imaging. In addition to mitigating the side effects of adenosine, there is generally less hepatic uptake of radiotracer and a higher heart/background ratio, which improves overall imaging quality. In limited studies, this improved imaging quality has translated into improved sensitivity and additional prognostic implications, with an inability to walk associated with greater adverse risk. In two clinical trials that directly compared dobutamine stress myocardial perfusion imaging with stress echocardiography, the sensitivities were 86% and 80%, and specificities were 73% and 86%. The sensitivity of detecting coronary artery disease increases incrementally with the extent of disease involvement. Dobutamine stress myocardial perfusion imaging has a sensitivity of 80%, 92%, and 97% for one- Post-infarct Myocardial Imaging In the United States, most patients presenting with myocardial infarction undergo early definitive risk stratification with coronary angiography. There is still a role, however, in low-risk myocardial infarction patients for predischarge noninvasive risk stratification in lieu of an early invasive strategy. Pharmacologic stress imaging has numerous advantages over exercise stress testing. Dobutamine and vasodilator use early after a myocardial infarction have the potential for adverse hemodynamic events, but have been shown to be safe in multiple cardiac imaging studies 2 days after an acute ischemic event. If pharmacologic imaging shows a significant degree of ischemia or infarction in the infarct zone, referral to cardiac catheterization would be indicated. Pharmacologic imaging in the post­myocardial infarction period provides significantly better prognostic information compared with submaximal exercise stress testing because pharmacologic stress imaging identifies the infarct and ischemic territories. As with all types of stress testing, patient selection is crucial, and certain underlying conditions may make pharmacologic stress testing better than exercise testing, even in patients with normal functional capacity. Patient Selection Beyond patients who are unable to exercise, pharmacologic stress imaging, whether with vasodilators or inotropic agents, is often the study of choice. In patients with active wheezing or a propensity for bronchospasm, it is preferable to avoid adenosine and dipyridamole, both of which have cross-reactivity with the adenosine A3 receptor, which can induce bronchoconstriction. Prophylactic bronchodilator use before vasodilator infusion is also an option, although limited data are available to support routine use with standard protocols. Table 26-2 reviews many of these conditions, most of which have been described in this chapter. Viability Assessment with Dobutamine Patients with ischemic heart disease may have large territories of dysfunctional myocardium that may recover function on revascularization. The detection of this myocardial viability is uniquely suited to dobutamine as a stress agent. Examinations using a protocol of low dose followed by higher doses of dobutamine infusion with the aid of echocardiography may unmask areas of viability. At low doses, the ventricular myocardium would show an improvement in contractility compared with the resting state, but at higher doses, owing to increasing oxygen demand, would show a decrement in function. Many small studies have shown a survival advantage and an improvement in global left ventricular function in patients with viability who underwent surgical revascularization compared with medical therapy alone. Similar to the detection of coronary artery disease, dobutamine stress myocardial perfusion imaging shows a higher sensitivity and lower specificity for the identification of myocardial viability than echocardiography. Exercise stress imaging is the preferred stress modality in patients who can exercise and achieve an adequate workload. When patients are able to complete only a submaximal (<85% target heart rate) exercise protocol, stress imaging becomes less sensitive and can underestimate the degree and extent of ischemia. It has been estimated that at least 25% of outpatients and 50% of hospitalized patients cannot perform adequate exercise to achieve a maximum workload. The safety record and side-effect profile of all pharmacologic agents are highly favorable for inpatient and outpatient care in a broad range of patients and disease states. The sensitivity and specificity of adenosine, dipyridamole, and dobutamine rival that of exercise stress imaging. Under certain clinical conditions, these agents are superior in improving test accuracy and minimizing falsepositive results. The diagnostic and prognostic information achieved through pharmacologic stress imaging is excellent and incremental to the other clinical parameters measured during the course of stress testing. The cardiovascular evaluation of patients unable to exercise because of underlying comorbidities, such as degenerative joint disease, vascular disease, lung disease, and other conditions, has been enhanced through pharmacologic stress testing. Pharmacologic stress imaging with vasodilators and inotropes provides key clinical insights into the mechanisms of ischemic heart disease, and is instrumental in the diagnosis and associated prognosis of coronary artery disease. Beyond stress/rest mismatch, nuclear stress imaging uses other indices to delineate higher risk studies. Vasodilators such as adenosine and dipyridamole and inotropes such as dobutamine are safe and tolerated in most clinical conditions. In the evaluation of coronary artery disease, pharmacologic stress imaging provides excellent diagnostic and prognostic information, similar to that achieved with exercise. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiacrelated hospital admissions. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. Prognostic value of dobutamine stress technetium-99m sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. Functional abnormalities in patients with permanent right ventricular pacing: the effect of the sites of electrical stimulation. Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Diganostic value of 12 lead electrocardiogram during dobutamine echocardiographic studies. Pharmacologic stress testing for coronary artery disease diagnosis: a meta-analysis. During the last 20 years, two major developments in the field have transformed the use of imaging in clinical management: (1) with the development of interventional catheter-based treatment strategies, the majority of common congenital heart diseases are now treated in the catheterization laboratory instead of in the operating suite; and (2) because of the successful treatment of children with congenital heart disease, there are now as many adults living with congenital heart disease as there are children. These changes have led to the evolution and use of imaging techniques to guide procedural treatments applicable to infants, children, and adults. This chapter reviews the common percutaneous interventional procedures for the treatment of congenital heart disease and illustrates the key role that imaging plays in their success. This defect typically occurs sporadically but has been linked to genetic abnormalities such as Holt-Oram syndrome and mutations on chromosome 5p. Technology and technique have been modified and refined over the years; however, the procedure remains conceptually identical. Patients who are hypercoagulable, particularly those with disorders that predispose to arterial clots, should be considered very carefully as the post-placement risk of clot formation during the endocardialization process may be significantly increased. Patients with pulmonary hypertension must be considered carefully but may benefit as long as there is a left-to-right shunt at rest. Outcomes and Complications Concurrent controlled trials comparing surgical closure with device closure have shown efficacy rates of more than 96% with significantly lower complication rates and hospital stay. Serious complications have been rare but include thrombus formation on the device, heart block requiring pacing, and cardiac perforation. This includes specific attention to the pulmonary vein drainage as well as to the size and location of the defect, including tissue rims to the atrioventricular valves, inferior vena cava, right pulmonary veins, aortic valve, and roof of the atrium. If the transthoracic study is inadequate to delineate these structures, OmniPlane transesophageal echocardiography should be performed. Documentation of an adequate atrial septal rim circumferentially (>3 mm, especially at the posterior inferior inlet portion;. Certainly, these modalities improve detection of an anomalous pulmonary vein and give a more complete understanding of the shape of the defect. This may permit more accurate measurement of the longaxis dimension of the defect, which is helpful for choosing the appropriate type and size of device. Procedural imaging for device implantation is a combination of echocardiography and biplane fluoroscopy. In my practice, I use surface echocardiography for implantation in children younger than 6 years. Transesophageal echocardiography is used in older patients in some institutions; however, it necessitates general anesthesia for the procedure. Balloon sizing of the defect is often done and can be useful to detect multiple defects. Postoperative Surveillance the cornerstone of surveillance after implantation remains transthoracic echocardiography. Patients are seen 1, 6, and 12 months after implantation to ensure appropriate device position, to rule out thrombus formation, and to assess right ventricular size and function. Commonly used devices have different imaging properties by echocardiography and radiography. It is present in all fetuses during development to direct oxygenated venous return from the placenta through the inferior vena cava across the atrial septum, bypassing the right ventricle and unexpanded lungs, to fill the left ventricle, allowing optimal cerebral perfusion. This is physiologically insignificant for most people unless the amount of right-to-left shunting is significant, causing orthodeoxiaplatypnea syndrome, or an embolus crosses right to left, resulting in a cryptogenic transient ischemic attack or stroke. Patients who are hypercoagulable, particularly those with disorders that predis- pose to arterial clots, should be considered very carefully as the post-placement risk of clot formation on the device during the endocardialization process may be significantly increased. However, those patients who are predisposed to venous clots may be the very patients who benefit the most in the long term, albeit with a potentially increased thrombus risk during the first 6 months after implantation. Patients who require anticoagulation long term for other issues may obtain limited benefit from device closure. More definitive information about recurrent stroke risk will be available from controlled randomized trials now under way comparing device closure with medical therapy. Procedural complications are uncommon, occurring in fewer than 2% of patients; they include stroke, transient ischemic attack, transient myocardial ischemia (these three due to air or clot embolism with the large delivery sheaths in the left atrium), device malposition or embolization, cardiac perforation with tamponade, and local femoral vein injury. Stroke associated with paradoxical embolism is a diagnosis of exclusion, so it is imperative to rule out other potential causes of stroke including cerebral aneurysm, carotid or vertebral vessel abnormalities, atrial arrhythmias, left atrial appendage thrombus, cardiomyopathy, and a hypercoagulable state. This work-up is essential to help guide decisions about the appropriateness of implanting a device and the optimal medical strategy during the endocardialization process. Because of a small incidence of atrial arrhythmias after device placement, a baseline electrocardiogram should also be obtained. Procedural imaging includes fluoroscopy with or without echocardiography, most commonly intracardiac imaging. Transesophageal echocardiography with saline contrast should be performed at 6 months if there is an abnormal or questionable thoracic echocardiographic study. Quantification of a residual shunt by transcranial Doppler examination is useful to determine the need for repeated intervention. Normal ductal closure occurs within the first 12 hours after birth by contraction and cellular migration of the medial smooth muscle in the wall of the ductus, resulting in protrusion of the thickened intima into the lumen, causing functional closure. Final closure with creation of the ligamentum arteriosum is completed by 3 weeks of age; permanent sealing of the duct by infolding of the endothelium, disruption of the internal elastic lamina, and hemorrhage and necrosis in the subintimal region lead to replacement of muscle fibers with fibrosis. This process of closure is incomplete in 1 in 2000 live births and accounts for up to 10% of all congenital heart disease. It is a particularly attractive technique in adults, in whom surgical ligation and division can be a problem because of calcified ductal tissue and increased surgical risks. Several different closure devices are currently used because of the significant variability of ductal anatomy. The most common anatomic shape is conical with a large aortic ampulla that narrows at the pulmonary artery end; however, other distinct anatomic forms exist, including "tubular" without a narrowing at the pulmonary artery end, "complex" with narrowing at both the aortic and pulmonary ends, and a short "window" that is an anatomy commonly found in adults. For large ducts, antegrade placement of an Amplatzer duct occluder device is the preferred method. In all but a very few patients, the coils can be snared from their embolized position in the pulmonary artery and removed from the body without sequela. Device embolization, thrombus, and ductal aneurysm have been reported in fewer than 1%. Controlled trials comparing antibiotic prophylaxis with device closure for the prevention of endocarditis have not and will not be performed because of the limited number of patients and the low incidence of endocarditis. There have been no late reports of endocarditis after interventional closure of the ductus, although procedural infections have occurred rarely. Imaging Findings Preoperative Planning A complete physical examination and thoracic echocardiography are necessary to make the diagnosis before intervention. Transthoracic echocardiography will show an abnormal systolic left-to-right color flow jet into the main pulmonary artery or proximal left pulmonary artery directed inferiorly and anteriorly. The central pulmonary arteries will be dilated, as will the left atrium and left ventricle if the shunt is significant. Unusual variations of the ductus arteriosus include origin from the inferior aspect of the transverse arch and from the proximal innominate or subclavian artery. The anatomy of the ductus can vary significantly; the most common is conical, with the narrowing at the pulmonary artery end. These various ductal anatomies can all be closed interventionally but require a variety of closure devices.

Syndromes

• Are you vomiting blood?
• Calling or e-mailing a pharmacy to order the medicine
• Intellectual disability
• Dengue virus
• The fewer children a woman has and the later in life she gives birth, the higher her risk of ovarian cancer.
• Confusion
• Changes in glucose metabolism
• Walks up stairs while holding on with one hand
• Some medications, including drugs used to treat high blood pressure (hypertension) and some mood-altering drugs
• Breast tenderness

A prewinding gradient is required to start the acquisition with negative spatial frequencies medicine hat jobs 100 mg retrovir buy overnight delivery. The measurement is repeated with stepwise changing phase-encoding gradients for sampling along the frequency-encoding direction with different offsets in the phase-encoding direction ky treatment quinsy discount retrovir 100mg fast delivery. The signed area under the gradients steers the sampling path medicine 6 year in us purchase retrovir with paypal, here shown for two phase-encoding settings (orange and blue) and their characteristic time points A symptoms kidney failure dogs discount retrovir 300 mg mastercard, B symptoms kidney cancer order 300 mg retrovir mastercard, C, and D. Theoretically, this concept could be repeated in orthogonal directions ultimately to excite only a single point in the object, and then repeat the measurement until all points in the image are sampled. A second linear field gradient, called the frequencyencoding gradient, is applied during data sampling so that the precession frequency of the net magnetization varies linearly. Thus, the detected signal becomes a summation of all encoded frequencies and its spatial distribution can be derived by a one-dimensional Fourier transform. Unfortunately, the second spatial dimension cannot be encoded simultaneously during readout because this would result in a nonunique allocation of frequency and spatial location. Instead, the gradients are applied sequentially, with the drawback of extended imaging times. The third gradient, called the phase-encoding gradient, is switched on and off prior to the frequency-encoding gradient. This leads to a linearly varying phase of the net magnetization vectors along the direction of that gradient, providing encoding for a single spatial frequency. If that experiment is repeated several times with varying phase-encoding gradients, then multiple spatial frequencies are sampled in the phase-encoding direction as well and an image can be reconstructed via inverse two-dimensional Fourier transform. The received signal is digitized by an analog to digital converter and a discrete inverse twodimensional Fourier transform generates the corresponding image, which contains magnitude (length of the transversal magnetization) and phase information (position in the transverse plain in respect to the coil axis) for each voxel. Suppose an acquisition matrix contained 256 data points in the frequency and 256 data points in the phaseencoding direction. For a two-dimensional acquisition, the total scan time is given by the number of phase-encoding steps multiplied by the repetition time. Volumetric imaging can be accomplished by successive imaging of two-dimensional slices. The acquired complex k-space data are reconstructed into image space via a 2D Fourier transform. The resulting signal has a magnitude and a phase component, representing the transversal magnetization Mxy and its position in a unit circle in respect to a receiver axis. The highest signal can be obtained with a flip angle of = 90 degrees, which tips the magnetization vector completely into the transversal plane. For this image, most of the signal energy is located around the origin of k-space. This area defines the weighting for the low spatial frequencies, which define the coarse outline of the imaged object yet lacks information on edges. However, all the detail is lost, which is defined in the unsampled higher spatial frequencies. The difference in images between the low-resolution images and the fully sampled image reveals the errors caused by limiting the acquisition to lower spatial frequencies only. The upper row is reconstructed when the central 512 × 512 (full resolution), 128 × 128, 64 × 64, and 32 × 32 samples are used for the reconstruction. The lower row represents reconstruction results when the remaining peripheral k-space data are used for the image reconstruction instead. Whereas the central k-space samples define the low spatial frequencies and most of the image contrast, the peripheral k-space data define the higher spatial frequencies and, therefore, fine structures and edges. Image outer k-space superimpose linear field gradients onto the main field for spatial encoding. The magnetic induction of the field, also frequently referred to as the magnetic field strength, is measured in tesla (T) or gauss (G), where 1 T = 104 G. They operate near absolute zero temperature (~4 K, or -270° C) to effectively eliminate electrical resistance in the coil wires, allowing large currents that generate high magnetic fields. The patient table, connectors for external transmit-receive or receive-only coils, and physiologic monitoring equipment are also shown. The main magnetic field is aligned with the table axis, called the z-axis by convention. Bird cage coils for head (A) and knee (B) imaging are single-coil transmit and receive coils with a very homogeneous B1 field. Single-channel surface coils such as the shoulder coil (C) or general purpose flex coil (D) are designed to have a high local sensitivity. Multielement coil arrays can combine the benefits of local sensitivity and larger coverage, here shown for an eight-channel neurovascular coil (E), eight-channel body phased-array coil (F), four-channel lower extremity coil (G), and eight-channel lower leg coil (H). This is accomplished by a transmitter coil tuned to the resonance frequency of the spin system under investigation. Such coils are designed to provide a uniform B1 field over the imaging volume to ensure uniform spin excitation. So-called birdcage coils are well suited for this purpose and exist as whole-body coils built into the scanner housing and as specialty coils, such as for head or knee imaging. However, in many applications, it is advantageous to use special local coils that are sensitive only to the signal from the region close to the coil. Gradient System the magnetic field gradient system typically consists of three orthogonal gradient coils embedded within the housing of the scanner. Gradient coils are designed to produce a spatially varying magnetic field that can be temporally altered. Although these additional magnetic fields are dramatically smaller than the main magnetic field, they are an essential component for spatial encoding of the signal distribution in the imaging volume of interest. Gradients are rated by their maximum gradient strength (the higher the better) and the time needed to rise to the maximum gradient strength (slew rate-the faster the better). Gradient systems have undergone dramatic improvements over the last decade and modern equipment can provide maximum gradient strengths of about 50 mT/m and slew rates of 200 T/m/s. Shown are images reconstructed for each individual coil with increased local sensitivity (small images) and after combining all images as the square root of the sum of the squares from all individual coil images. Data from multiple coils cannot be combined during acquisition and must be stored individually. Therefore, the acquired data size increases linearly with the number of coils, and image reconstruction must be completed for each channel before they can be combined. However, current reconstruction engines are prepared to handle the additional workload for 8 to 16 channels without significant delays. Parallel Imaging More recently, scan time reduction methods were developed that explore the redundancy in the information contained in multiple receiver coils with partly overlapping sensitivity regions. With this approach, the equivalent of multiple-phase encoding steps is acquired during a single readout. The scan time reduction factor that can be obtained with parallel imaging depends on the number of independent coil elements and their arrangement. Therefore, further increases in the number of coil elements and receiver channels promise even greater reductions in scan time. Consequently, the recent progress in parallel imaging has led to renewed interest in coil design and receiver systems. Current design problems, such as with the decoupling of individual coil elements, has limited commercial coil designs to 8 to 32 elements. These enlarged T waves can cause problems in gated acquisitions when they are mistaken as the trigger point from the R wave. The setup for these measurements is simple but the signal has a less distinct peak within the cardiac cycle for gating, making it less desirable for acquisitions that need precise synchronization. Stress transducer systems provide a similarly simple approach for the tracking of the respiratory cycle. However, they can lack precision because they track the abdominal circumference instead of the targeted image area, can undergo baseline drifts, and can pose difficulties in shallow breathers. A more precise but also more complex approach is the use of navigator echoes that track the position of the lung-liver interface. The injection of the contrast agent is followed by the injection of sterile saline to flush the contrast material out of the delivery system and ensure that the contrast bolus is sufficiently central within the body. The power injector is more precise in delivering reproducible injection rates and its use omits the need for an operator in the scan room during imaging. Power injectors also provide features to assist in dynamic timed studies and breath-hold maneuvers and allow for multiphase injections. A typical system consists of a delivery component in the scan room and a user console in the operator room. Manual injections have the advantage that the physician is right next to the patient and can better monitor the administration of contrast agent and the status of the patient. A computer-controlled delivery system injects the contrast agent and the saline flush into the antecubital vein through a common line. Because of the toxicity of Gd in pure form, it is chelated with ligands in formulations used in clinical practice. The contrast medium bolus is intravenously administered, usually with a power injector at a fixed rate. The specifics of the injection protocol should be tailored for the vascular territory, imaging pulse sequence, contrast agent, and specific condition and circulatory time of the patient. Short repetition times leave little time for signal regrowth between successive excitations and form the basis for good background suppression. Therefore, only tissues with a short T1 time will generate significant signal contributions. A pitfall of this technique is its application in regions of the body where there is an abundance of fat in the surrounding background tissue. In these cases, the signal of surrounding fat may diminish the apparent contrast-to-noise discrimination of the arterial segments from signal of surrounding fat. Bolus Timing for Contrast-Enhanced Magnetic Resonance Angiography To optimize image quality, the data acquisition has to be synchronized with the contrast bolus transit through the target vasculature, which is typically arterial. The imaging objective is thus to capture critical image data during the arterial first passage of the bolus prior to contrast bolus progression and signal enhancement of the veins, and prior to significant dilution of the contrast bolus within the arterial tree. The simplest way to estimate the arrival time of the bolus is the best guess technique. Contrast bolus arrival time can be determined for an individual patient by performing a preliminary timing scan with a low dose of contrast agent. Based on these images, the arrival time for a full injection is predicted and a suitable delay time for the start of the data acquisition is determined. Note the patent pancreas transplant artery (arrows), renal transplant artery, and accessory renal transplant artery (open arrows). Also, the arrival time of the contrast may vary because of differences in breathing or the initiation of a breath-hold. In some cases, such as with the carotid arteries, this window can be as brief as 5 seconds. For example, if one wants to acquire a cubic volume with an isotropic spatial resolution of 256 voxels in each dimension. Instead, a reduced data set is sampled to limit the scan duration to 10 to 30 seconds, either with compromised spatial resolution by symmetrical k-space reduction. After venous injection of the contrast agent, the bolus travels through the right ventricle, pulmonary system (A), and left ventricle before it enters the systemic vasculature (B). It then enters the venous system through the capillary bed (C) and transition of the contrast material from the intravascular compartment into interstitial space occurs (C, D). Usually, images from the arterial phase (B) are desired to visualize arteries with high contrast to the surrounding tissue and veins. K-Space View Ordering If it were possible to extend the scan time beyond the period of preferential arterial enhancement. To this end, sampling schemes have been developed that tailored the temporal order of the phase-encoding steps to optimize image quality. The first acquired view in such a scheme is the most distant from the origin of k-space. Line after line of k-space is acquired linearly by advancing one phase encode (here, kz) from its minimum to its maximum, while the other phase encode is kept constant (here, ky). However, this scheme is not well suited to ensure sampling of the central k-space region during peak arterial enhancement. To this end, centric view-encoding k-space schemes were developed whereby the views near the k-space origin are acquired during the initial period of the scan. Centric view encoding k-space schemes facilitate better synchronization of key central k-space image data acquisition with the arrival of the contrast bolus. A further optimized variation of this scheme is the so-called elliptical centric view ordering. The larger the distance between a k-space point and the origin, the later that particular kx line is sampled. Scan time savings can be achieved if a smaller matrix is sampled, such as with compromised spatial resolution in a phase-encoding direction (B), reduced coverage in a phase-encoding direction (C), partial Fourier acquisitions that assume certain symmetries in k-space (D), reduction of phase-encoding steps with parallel imaging (E), or a combination of these techniques. Here these schemes are shown for reductions in ky but, in practice, they can also be used in kz or in both phase-encoding directions. Each readout is represented by a dot and the readout direction is perpendicular to the shown ky-kz plane. It is also more robust to artifacts generated by the modulation of the contrast concentration and suppression of motion artifacts. Elliptical centric view ordering is particularly helpful for imaging arterial territories such as the carotid arteries, which can have especially brief periods of preferential arterial enhancement. With proper frame rates, arterial-only images are obtained without the need for any synchronization of the acquisition and arrival of the bolus.

Cheap retrovir 300mg buy line. Robert Parker- Early Symptoms [Full EP].

References

• KiihlJT, L1lnborgJ, Fuchs A, et al. Assessment ofleft atrial volume and function: a comparative study between echocardiography, magnetic resonance imaging and multi slice computed tomography. Int ] Cardiovasc Imaging 2012;28{5):1061-1071.
• Weigelt J, Itani K, Stevens D, et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005;49:2260-2266.
• Simon LS, Mills JA. Drug therapy: nonsteroidal antiinflammatory drugs [first of two parts]. N Engl J Med 1980;302:1179.
• Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 2000;232:175-80.
• Glogau RG, Stegman SJ, Tromovich TA. Refinements in split thickness skin grafting technique. J Dematol Surg Oncol 1987;13:853-858.